MedTrace Logo

Endothelial Dysfunction, Biomarkers, and Lung Function -Ancillary to MESA

NCT00843271 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 4359

Last updated 2026-04-23

No results posted yet for this study

Summary

The purpose of the MESA Lung Study is to assess the role of endothelial dysfunction and genetic susceptibility to subclinical COPD and emphysema.

Conditions

  • Chronic Obstructive Pulmonary Disease (COPD)
  • Emphysema
  • Endothelial Dysfunction

Sponsors & Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

    collaborator NIH

  • Columbia University

    lead OTHER

Principal Investigators

  • R. Graham Barr, M.D., Dr.PH. · Columbia University

Eligibility

Min Age
45 Years
Max Age
84 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-10-31
Primary Completion
2027-01-31
Completion
2027-01-31

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00843271 on ClinicalTrials.gov